Cargando…

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines

Coronavirus disease 2019 (COVID-19) pandemic is a serious threat to global public health and social and economic development. Various vaccine platforms have been developed rapidly and unprecedentedly, and at least 16 vaccines receive emergency use authorization (EUA). However, the causative pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yandi, Banga Ndzouboukou, Jo-Lewis, Gan, Mengze, Lin, Xiaosong, Fan, Xionglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645832/ https://www.ncbi.nlm.nih.gov/pubmed/34880867 http://dx.doi.org/10.3389/fimmu.2021.771242

Ejemplares similares

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery
por: Hao, Ling, et al.
Publicado: (2020)

Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
por: Lei, Qing, et al.
Publicado: (2021)

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Roles and functions of SARS-CoV-2 proteins in host immune evasion
por: Rashid, Farooq, et al.
Publicado: (2022)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains
por: Ullah, Nadeem, et al.
Publicado: (2021)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

The Immunological Synapse: An Emerging Target for Immune Evasion by Bacterial Pathogens
por: Capitani, Nagaja, et al.
Publicado: (2022)

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
por: Thompson, Robin N., et al.
Publicado: (2023)

IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA
por: Zheng, Qingcong, et al.
Publicado: (2022)

A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells
por: Yu, Qi, et al.
Publicado: (2017)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Spirochetal Lipoproteins and Immune Evasion
por: Christodoulides, Alexei, et al.
Publicado: (2017)

Immune Evasion Strategies of Schistosomes
por: Hambrook, Jacob R., et al.
Publicado: (2021)

Innate immune evasion by alphaviruses
por: Liu, Yihan, et al.
Publicado: (2022)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
por: Jian, Yuli, et al.
Publicado: (2021)

The Emerging Role of STING in Insect Innate Immune Responses and Pathogen Evasion Strategies
por: Liu, Qiuning, et al.
Publicado: (2022)

The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
por: Wang, Zhihui, et al.
Publicado: (2021)

HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
por: Loi, Eleonora, et al.
Publicado: (2022)

Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant
por: Yang, Yi, et al.
Publicado: (2019)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
por: Chen, Qiuli, et al.
Publicado: (2022)

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
por: Sun, Cong, et al.
Publicado: (2022)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

SARS‐CoV‐2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion
por: Quaglia, Federica, et al.
Publicado: (2022)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Universal immunity to influenza must outwit immune evasion
por: Quiñones-Parra, Sergio, et al.
Publicado: (2014)

Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica
por: Nakada-Tsukui, Kumiko, et al.
Publicado: (2016)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

SARS-CoV-2 Delta variant excels at membrane fusion, but not immune evasion
por: Flemming, Alexandra
Publicado: (2021)

The viral phoenix: enhanced infectivity and immunity evasion of SARS-CoV-2 variants
por: Choi, Hosoon, et al.
Publicado: (2021)

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
por: Cai, Yongfei, et al.
Publicado: (2021)

Covid-19: Perspectives on Innate Immune Evasion
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8fanf57a66jpm098im66hstegl